Lista de obras - Marie-Christine Chartier-Harlin

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively

scientific article published on 17 March 2022

A new GTP-cyclohydrolase I mutation in an unusual doparesponsive dystonia, familial form

artículo científico publicado en 1999

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

artículo científico publicado en 1998

A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease.

artículo científico publicado en 2004

A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.

artículo científico publicado en 2002

A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells

artículo científico publicado en 2024

ATXN2 a culprit with multiple facets.

artículo científico publicado en 2017

Alpha-2 macroglobulin gene and Alzheimer disease.

artículo científico publicado en 1999

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

scientific article published in The Lancet

Alpha-synuclein repeat variants and survival in Parkinson's disease

artículo científico publicado en 2014

Alzheimer disease: the new agenda ⬇️

artículo científico publicado el 1 de marzo de 1992

Alzheimer's disease: A beta or ApoE amyloidosis?

artículo científico publicado en 1995

Alzheimer's--a correction

artículo científico publicado el 2 de abril de 1992

Analysis of the APOE alleles impact in Down's syndrome

artículo científico publicado en 1996

Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes

article

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

artículo científico publicado en 1998

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study

artículo científico publicado en 2003

Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease.

artículo científico publicado en 1999

Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

artículo científico publicado en 1997

Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease

artículo científico publicado en 2003

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study ⬇️

artículo científico publicado en 2011

Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease

artículo científico publicado en 2005

Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease.

artículo científico publicado en 2002

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

artículo científico publicado en 2004

Characterization of DCTN1 genetic variability in neurodegeneration.

scientific article published on June 2009

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

artículo científico publicado en 2006

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes

artículo científico publicado en 2017

Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis.

artículo científico

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

artículo científico publicado en 1997

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

artículo científico publicado en 2001

Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.

artículo científico publicado en 1995

GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.

artículo científico publicado en 2017

Genomic investigation of alpha-synuclein multiplication and parkinsonism

artículo científico publicado en 2008

In silico and Wet Bench Interactomics Sheds Light on the Similitudes and Differences between Human ROCO Proteins

scientific article published on 13 June 2018

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

artículo científico publicado en 2011

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

article

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

artículo científico publicado en 2004

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease

artículo científico publicado en 2013

Is the LDL receptor-related protein involved in Alzheimer's disease?

artículo científico publicado en 1999

Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways.

artículo científico publicado en 2016

LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?

artículo científico publicado en 2017

Linkage exclusion in French families with probable Parkinson's disease

article

NADPH oxidases in Parkinson's disease: a systematic review

artículo científico publicado en 2017

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms.

artículo científico publicado en 2001

No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

artículo científico publicado en 1999

No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.

artículo científico publicado en 2002

No association of the HLA-A2 allele with Alzheimer's disease

artículo científico publicado en 2002

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice

artículo científico publicado en 2018

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2.

artículo científico publicado en 2017

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

artículo científico publicado en 2018

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium

artículo científico publicado en 2013

Prenatal stress has pro-inflammatory consequences on the immune system in adult rats.

artículo científico publicado en 2007

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

artículo científico publicado en 2013

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

artículo científico publicado en 2011

S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship

article

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

artículo científico publicado en 2011

Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile

artículo científico publicado el 1 de junio de 1992

Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE

artículo científico publicado en 1999

The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.

artículo científico publicado en 2001

The Cystatin-C gene is not linked to early onset familial Alzheimer's disease

scientific article published on 01 May 1993

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

artículo científico publicado en 2017

Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation

artículo científico publicado en 2010

Transcriptomic signatures of brain regional vulnerability to Parkinson's disease

artículo científico publicado en 2020

Translation initiator EIF4G1 mutations in familial Parkinson disease

artículo científico publicado en 2011

UCHL1 is a Parkinson's disease susceptibility gene

artículo científico publicado en 2004

Xenopus laevis as a Model to Identify Translation Impairment.

artículo científico publicado en 2015

[Genetic complexity of Alzheimer's disease]

artículo científico publicado en 2004

Lista de obras de Marie-Christine Chartier-Harlin

A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively

A new GTP-cyclohydrolase I mutation in an unusual doparesponsive dystonia, familial form

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

A polymorphism in the angiotensin 1-converting enzyme gene is associated with damage to cerebral cortical white matter in Alzheimer's disease.

A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.

A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells

ATXN2 a culprit with multiple facets.

Alpha-2 macroglobulin gene and Alzheimer disease.

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

Alpha-synuclein repeat variants and survival in Parkinson's disease

Alzheimer disease: the new agenda ⬇️

Alzheimer's disease: A beta or ApoE amyloidosis?

Alzheimer's--a correction

Analysis of the APOE alleles impact in Down's syndrome

Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study

Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease.

Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study ⬇️

Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease

Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease.

CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease

Characterization of DCTN1 genetic variability in neurodegeneration.

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes

Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis.

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.

GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.

Genomic investigation of alpha-synuclein multiplication and parkinsonism

In silico and Wet Bench Interactomics Sheds Light on the Similitudes and Differences between Human ROCO Proteins

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease

Is the LDL receptor-related protein involved in Alzheimer's disease?

Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways.

LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?

Linkage exclusion in French families with probable Parkinson's disease

NADPH oxidases in Parkinson's disease: a systematic review

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms.

No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.

No association of the HLA-A2 allele with Alzheimer's disease

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice

PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2.

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium

Prenatal stress has pro-inflammatory consequences on the immune system in adult rats.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease

S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship

SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile

Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE

The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.

The Cystatin-C gene is not linked to early onset familial Alzheimer's disease

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation

Transcriptomic signatures of brain regional vulnerability to Parkinson's disease

Translation initiator EIF4G1 mutations in familial Parkinson disease

UCHL1 is a Parkinson's disease susceptibility gene

Xenopus laevis as a Model to Identify Translation Impairment.

[Genetic complexity of Alzheimer's disease]